Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
Inogen
INGN
$146M
| $698K | ﹤0.01% |
85,436
+11,593
| +16% | +$86.7K |
|
4752
Axsome Therapeutics
AXSM
$11B
| $697K | ﹤0.01% |
5,741
-24,878
| -81% | -$2.8M |
|
4753
Candel Therapeutics
CADL
$1.02B
| $697K | ﹤0.01% |
+136,670
| New | +$790K |
|
4754
CALL
McCormick & Company Non-Voting
MKC
$14.5B
| $696K | ﹤0.01% |
10,400
-1,500
| -13% | -$105K |
|
4755
Columbia Financial
CLBK
$1.21B
| $696K | ﹤0.01% |
46,338
+21,254
| +85% | +$317K |
|
|
MREO
4756
Mereo BioPharma
MREO
$44.6M
| $695K | ﹤0.01% |
337,503
-258,170
| -43% | -$476K |
|
|
LADR
4757
Ladder Capital
LADR
$1.26B
| $694K | ﹤0.01% |
63,582
-48,013
| -43% | -$540K |
|
4758
PUT
Ollie's Bargain Outlet
OLLI
$4.48B
| $693K | ﹤0.01% |
5,400
-8,300
| -61% | -$1.1M |
|
4759
CALL
Organon & Co
OGN
$3.61B
| $693K | ﹤0.01% |
64,900
-197,900
| -75% | -$1.94M |
|
4760
MGP Ingredients
MGPI
$377M
| $692K | ﹤0.01% |
28,621
+12,183
| +74% | +$353K |
|
4761
Sotera Health
SHC
$5.58B
| $692K | ﹤0.01% |
44,005
-480,557
| -92% | -$6.75M |
|
4762
PUT
Domino's
DPZ
$11.4B
| $691K | ﹤0.01% |
1,600
-500
| -24% | -$227K |
|
4763
PUT
Warby Parker
WRBY
$3.21B
| $690K | ﹤0.01% |
+25,000
| New | +$632K |
|
|
BRRWU
4764
DELISTED
Columbus Circle Capital Corp I Units
BRRWU
| $687K | ﹤0.01% |
64,303
-132,442
| -67% | -$1.46M |
|
4765
PUT
SentinelOne
S
$7.01B
| $687K | ﹤0.01% |
+39,000
| New | +$700K |
|
4766
Emergent Biosolutions
EBS
$294M
| $686K | ﹤0.01% |
77,824
-677,608
| -90% | -$5.27M |
|
4767
CALL
Host Hotels & Resorts
HST
$15.5B
| $686K | ﹤0.01% |
40,300
-21,700
| -35% | -$360K |
|
4768
PUT
Peloton Interactive
PTON
$2.34B
| $681K | ﹤0.01% |
75,700
-1,572,000
| -95% | -$11.7M |
|
4769
PUT
Algoma Steel
ASTL
$427M
| $679K | ﹤0.01% |
191,100
+112,400
| +143% | +$597K |
|
|
EMX
4770
DELISTED
EMX Royalty
EMX
| $678K | ﹤0.01% |
132,003
-78,737
| -37% | -$272K |
|
4771
Avita Medical
RCEL
$316M
| $678K | ﹤0.01% |
132,709
-236,483
| -64% | -$1.23M |
|
4772
CALL
YPF Sociedad Anonima ADS
YPF
$19.5B
| $678K | ﹤0.01% |
+27,900
| New | +$857K |
|
4773
SunCoke Energy
SXC
$822M
| $677K | ﹤0.01% |
83,023
-1,347,978
| -94% | -$10.7M |
|
4774
CALL
GXO Logistics
GXO
$5.54B
| $677K | ﹤0.01% |
+12,800
| New | +$658K |
|
4775
Grupo Aval
AVAL
$6.48B
| $675K | ﹤0.01% |
204,647
-36,524
| -15% | -$114K |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.